Get the Stockscreener App
0.395
1.91%
0.0074
Bone Biologics Corp stock is traded at $0.395, with a volume of 59,748.
It is up +1.91% in the last 24 hours and down -26.53% over the past month.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
See More
Previous Close:
$0.3876
Open:
$0.405
24h Volume:
59,748
Relative Volume:
1.25
Market Cap:
$1.09M
Revenue:
Net Income/Loss:
$-2.86M
P/E Ratio:
-0.1576
EPS:
-2.5071
Net Cash Flow:
$-2.57M
1W Performance:
-15.44%
1M Performance:
-26.53%
6M Performance:
-70.08%
1Y Performance:
-84.63%
1-Day Range:
$0.385
$0.409
1-Week Range:
$0.3788
$0.4661
52-Week Range:
$0.3788
$2.70
Bone Biologics Corp Stock (BBLG) Company Profile
Name
Bone Biologics Corp
Sector
Industry
Phone
(781) 552-4452
Address
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBLG
Bone Biologics Corp
|
0.395 | 1.09M | 0 | -2.86M | -2.57M | -2.5071 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Bone Biologics Corp Stock (BBLG) Latest News
Acurx Pharmaceuticals, Inc. (ACXP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bone Biologics Warrants (BBLGW) Jump 45.53% to $5.53 as Buyers Pile InSchiff Line - https://www.siam.in/
Bone Biologics Warrants (BBLGW) Jump 45.53% to $5.53 as Buyers Pile InDouble Top - https://www.dars.gov.et/
Form 4 Bone Biologics Corp For: 1 October By Investing.com - Investing.com South Africa
Form 4 Bone Biologics Corp For: 1 October By Investing.com - Investing.com UK
Form 4 Bone Biologics Corp For: 1 October By Investing.com - Investing.com Nigeria
Form 4 Bone Biologics Corp For: 1 October - Investing.com India
Form 4 Bone Biologics Corp For: 30 September By Investing.com - Investing.com Nigeria
Form 4 Bone Biologics Corp For: 30 September By Investing.com - Investing.com UK
114K options with a $0.50 exercise price go to Bone Biologics (BBLG) director Bruce Stroever. - Stock Titan
Bone Biologics shareholders approve board nominees and reverse stock split By Investing.com - Investing.com Nigeria
Form 8K Bone Biologics Corp For: 29 September By Investing.com - Investing.com India
Form 8K Bone Biologics Corp For: 29 September By Investing.com - Investing.com UK
These stocks are moving in today's pre-market session - ChartMill
BBLG Q2 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Developer Misses EstimateDividend Cut Risk - careplusvn.com
Bone Biologics (BBLG) faces Nasdaq $1 deadline and eyes reverse split - Stock Titan
BBLG Q2 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Developer Misses EstimatePretax Income Report - dars.gov.et
BBLG Q2 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Developer Misses Estimate - dars.gov.et
BBLG: Bone Biologics Corp Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bone Biologics expands Australian trial to six hospital sites - Investing.com Australia
Bone Biologics expands Australian trial to six hospital sites - Investing.com
Bone Biologics expands Australian trial to six hospital sites By Investing.com - Investing.com UK
Six Australian hospitals agree to join Bone Biologics' bone-graft trial - Stock Titan
Bone Biologics Corp (BBLG) Holds Flat at $0.56 Within Tight Trading RangeStrangle Setup - dars.gov.et
BBLGW 8-K FilingsBone Biologics Corp Warrants SEC 8-K - Stock Titan
A company developing bone products will meet investors in New York - Stock Titan
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Bone Biologics (NASDAQ: BBLGW) Schedules Six Key Proposals for September 28 Shareholder Vote - Kalkine Media
Bone Biologics Corp Warrants (BBLGW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Bone Biologics Corp Warrants (BBLGW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Orthobiologics Market Report Examines Leading Companies And Growth Opportunities - openPR.com
Bone Biologics (NASDAQ:BSPK): What Could Its Scheduled Update Reveal? - Kalkine Media
Bone (BBLG): Finishes 3.47% Higher at $0.63 in Latest Trading; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance for the Current SessionETF Outflow Streak - vinanet.vn
Bone (BBLGW): Shows Minimal Net Change at $8.24 in Latest Trading; Chart Watch: the Supplied Trading Band Runs From $7.83 to $8.65 under the Current SnapshotPut Flow Alert - siam.in
Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn
Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn
Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan
Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView
Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - tradingview.com
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Systematic Flow - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Volatility Breakout Picks - vinanet.vn
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Ichimoku Kumo Break - dars.gov.et
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Impulse Wave - careplusvn.com
Bone Biologics Corp (BBLG) Slips 2.86% as Shares Test Key Support at $0.63Zigzag Correction - dars.gov.et
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4OBV Divergence - dars.gov.et
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Bullish Sentiment - dars.gov.et
BBLGW Warrants Hold Flat at $7.05 as Bone Biologics Consolidates Between $6.7 and $7.4Wedge Breakout - www.dars.gov.et
Bone Biologics Raises $2.7M, Extends Cash Runway to Q2 2027 - Minichart
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Bone Biologics Warrants (BBLGW) Hold at $3.50 as Traders Eye Tight RangeEquity Put Call - dars.gov.et
Bone Biologics Corp Stock (BBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):